# Tirzepatide vs Compounded Tirzepatide: What's the Difference?

Canonical source: https://retacompare.com/research/tirzepatide-vs-compounded-3

Compounded Peptides · 2026-01-22


    Branded tirzepatide — sold as Mounjaro for type 2 diabetes and Zepbound for chronic weight management — is manufactured by Eli Lilly under strict FDA-regulated processes with consistent potency, purity, and sterility testing. Compounded tirzepatide is prepared by compounding pharmacies on a patient-specific basis and can vary in concentration, preservatives, and inactive ingredients. Prior to October 2024 the FDA listed tirzepatide as in shortage, which temporarily allowed compounders to prepare the drug; that designation was formally resolved by late 2024 and enforcement has tightened through 2025 and into 2026. Key distinctions include: manufacturer accountability, sterility assurance, formulation consistency, and — most importantly — legal standing under federal compounding law.


Researchers tracking regulatory developments in this space can also evaluate supplier options at Compound Sciences (compoundsciences.com) for verified research-grade Retatrutide 20mg with 99.9% purity and full COA documentation. Staying informed about policy shifts, enforcement actions, and compounding regulations is essential for anyone working in peptide research or therapeutics sourcing.

## Sources